Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

HSP70-IN-1

Copy Product Info
🥰Excellent
Catalog No. T3487Cas No. 1268273-90-0

HSP70-IN-1 is a heat shock protein (HSP) inhibitor that suppresses the growth of Kasumi-1 cells with an IC50 of 2.3 μM.

HSP70-IN-1

HSP70-IN-1

Copy Product Info
🥰Excellent
Purity: 99.91%
Catalog No. T3487Cas No. 1268273-90-0
HSP70-IN-1 is a heat shock protein (HSP) inhibitor that suppresses the growth of Kasumi-1 cells with an IC50 of 2.3 μM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$97In StockIn Stock
5 mg$239In StockIn Stock
10 mg$372In StockIn Stock
25 mg$653In StockIn Stock
50 mg$892In StockIn Stock
100 mg$1,230In StockIn Stock
1 mL x 10 mM (in DMSO)$243In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.91%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
HSP70-IN-1 is a heat shock protein (HSP) inhibitor that suppresses the growth of Kasumi-1 cells with an IC50 of 2.3 μM.
Targets&IC50
Caspase-3:1.9 μM (MOLM13 cells), HSP:2.3 μM, Caspase-7:1.9 μM (MOLM13 cells)
In vitro
Heat shock protein 70 (Hsp70) functions as a molecular chaperone crucial for protein homeostasis, cell signaling, and survival, with its overexpression observed in cancer contributing to chemotherapy resistance. HSP70-IN-1 disrupts this by dose-dependently affecting the formation and stability of the Hsp70-HOP-Hsp90 complex, crucial for cancer cell survival, including altering components of this megacomplex and destabilizing the Hsp70-Hsp90 machinery client, Raf-1. It also inhibits the refolding capability of endogenous and transfected Hsp70 for heat-denatured luciferase in cells, and induces apoptosis in cancer cells by modifying the Hsp70-HOP complex formation and stability, leading to their reduced half-life.
Chemical Properties
Molecular Weight464.58
FormulaC24H28N6O2S
Cas No.1268273-90-0
SmilesCN1CCN(CC1)c1ncc(Sc2cccc(NC(=O)CN)c2)c(OCc2ccccc2)n1
Relative Density.1.34 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 45 mg/mL (96.86 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.3 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1525 mL10.7624 mL21.5248 mL107.6241 mL
5 mM0.4305 mL2.1525 mL4.3050 mL21.5248 mL
10 mM0.2152 mL1.0762 mL2.1525 mL10.7624 mL
20 mM0.1076 mL0.5381 mL1.0762 mL5.3812 mL
50 mM0.0430 mL0.2152 mL0.4305 mL2.1525 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy HSP70-IN-1 | purchase HSP70-IN-1 | HSP70-IN-1 cost | order HSP70-IN-1 | HSP70-IN-1 chemical structure | HSP70-IN-1 in vitro | HSP70-IN-1 formula | HSP70-IN-1 molecular weight